New York Life Investment Management’s Nutanix NTNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.69M Sell
33,198
-40
-0.1% -$1.81K 0.01% 586
2026
Q1
$1.26M Buy
33,238
+9,142
+38% +$385K 0.01% 624
2025
Q4
$1.25M Sell
24,096
-1,973
-8% -$121K 0.01% 576
2025
Q3
$1.94M Sell
26,069
-578
-2% -$42.4K 0.02% 547
2025
Q2
$2.04M Sell
26,647
-721
-3% -$51.9K 0.02% 532
2025
Q1
$1.91M Buy
27,368
+194
+0.7% +$13.4K 0.02% 551
2024
Q4
$1.66M Sell
27,174
-837
-3% -$54.7K 0.02% 576
2024
Q3
$1.66M Sell
28,011
-1,606
-5% -$88.2K 0.02% 608
2024
Q2
$1.68M Buy
29,617
+2,691
+10% +$165K 0.02% 594
2024
Q1
$1.66M Buy
26,926
+200
+0.7% +$11.5K 0.02% 581
2023
Q4
$1.27M Buy
26,726
+986
+4% +$39.9K 0.01% 612
2023
Q3
$898K Buy
25,740
+13,457
+110% +$422K 0.01% 647
2023
Q2
$345K Buy
+12,283
New +$326K ﹤0.01% 1176

Other funds holding NTNX

New York Life Investment Management's NTNX Position: Q2 2026 in Review

New York Life Investment Management reduced its Nutanix (NTNX) stake by 0.12% in Q2 2026, selling an estimated $1.81K and leaving 33,198 shares worth $1.69M. The position accounts for 0.01% of the portfolio, ranked #586.

New York Life Investment Management first reported a position in NTNX in Q2 2023 and has held it in 13 quarters since. The position peaked at $2.04M in Q2 2025. 320 funds tracked by Wall St. Rank hold NTNX as of Q2 2026.

  • New York Life Investment Management held 33,198 shares of Nutanix worth $1.69M as of Q2 2026.
  • New York Life Investment Management sold 40 Nutanix shares in Q2 2026, an estimated $1.81K.
  • Nutanix made up 0.01% of New York Life Investment Management's portfolio in Q2 2026, its #586 holding.
  • New York Life Investment Management first reported a position in Nutanix in Q2 2023 and has held it in 13 quarters since.
  • New York Life Investment Management's Nutanix position peaked at $2.04M in Q2 2025.
  • 320 funds tracked by Wall St. Rank held Nutanix as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.